Benjamin F. Edwards & Company’s Prestige Consumer Healthcare PBH Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-370	Closed	-$19K	–	1613
2017 Q3	$19K	Buy	+370	New	+$18.9K	﹤0.01%	1003
2016 Q2	–	Sell	-309	Closed	-$16K	–	1119
2016 Q1	$16K	Sell	309 -44	-12%	-$2.17K	﹤0.01%	714
2015 Q4	$18K	Buy	353 +153	+77%	+$7.6K	﹤0.01%	721
2015 Q3	$9K	Sell	200 -350	-64%	-$16.5K	﹤0.01%	896
2015 Q2	$25K	Buy	550 +300	+120%	+$13.1K	0.01%	736
2015 Q1	$11K	Buy	250 +200	+400%	+$7.62K	﹤0.01%	877
2014 Q4	$2K	Buy	+50	New	+$1.66K	﹤0.01%	962

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MRCP

Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Benjamin F. Edwards & Company's PBH Position: Q4 2017 in Review

Benjamin F. Edwards & Company sold out of Prestige Consumer Healthcare (PBH) in Q4 2017, closing a stake of 370 shares — an estimated $19K sold.

Benjamin F. Edwards & Company first reported a position in PBH in Q4 2014 and held it in 7 quarters. The position peaked at $25K in Q2 2015. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

Benjamin F. Edwards & Company reported no remaining Prestige Consumer Healthcare position as of Q4 2017 after selling out during the quarter.
Benjamin F. Edwards & Company sold 370 Prestige Consumer Healthcare shares in Q4 2017, an estimated $19K.
Benjamin F. Edwards & Company first reported a position in Prestige Consumer Healthcare in Q4 2014 and held it in 7 quarters.
Benjamin F. Edwards & Company's Prestige Consumer Healthcare position peaked at $25K in Q2 2015.
251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2017, filed 17 Jan 2018.